Inventor · disambiguated record
Hans Martin Seidel
Also filed as: SEIDEL HANS MARTIN
12 granted patents·39 pending applications·9 citations·filing 2006–2024
84Inventor score
Top patents by PatentIndex Score
51 records- 0190US11724992B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2021·Granted Aug 15, 2023·1 cites·20 claims
- 0284US12084424B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2023·Granted Sep 10, 2024·0 cites·3 claims
- 0384US11370763B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2018·Granted Jun 28, 2022·1 cites·13 claims
- 0484US10654816B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS INFLAMMASOME RES INC·Filed 2019·Granted May 19, 2020·3 cites·19 claims
- 0583US12152018B2Compounds and compositions for treating conditions associated with STING activityIFM DUE INC·Filed 2022·Granted Nov 26, 2024·1 cites·36 claims
- 0681US11203579B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2018·Granted Dec 21, 2021·2 cites·19 claims
- 0777US2024391884A1Compounds and compositions for treating conditions associated with nlrp activityNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0870US11618749B2Compounds and compositions for treating conditions associated with STING activityIFM DUE INC·Filed 2019·Granted Apr 4, 2023·1 cites·12 claims
- 0970US2025136597A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2024·Application pending·0 cites
- 1065US12421223B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2019·Granted Sep 23, 2025·0 cites·1 claims
- 1165US2024083895A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2023·Application pending·0 cites
- 1262US2025084071A1Compounds and compositions for treating conditions associated with sting activityNOVARTIS PHARMA AG·Filed 2023·Application pending·0 cites
- 1360US12503436B2Compounds and compositions for treating conditions associated with STING activityNOVARTIS PHARMA AG·Filed 2022·Granted Dec 23, 2025·0 cites·86 claims
- 1460US2023079631A1Compounds and compositions for treating conditions associated with nlrp activityNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1559US2022024919A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2021·Application pending·0 cites
- 1658US2023250060A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2023·Application pending·0 cites
- 1756US2024076285A1Compounds and compositions for treating conditions associated with sting activityVENKATRAMAN SHANKAR·Filed 2021·Application pending·0 cites
- 1854US2024041843A1Methods of treating cancerIFM DUE INC·Filed 2021·Application pending·0 cites
- 1954US2024101556A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2022·Application pending·0 cites
- 2054US2024100017A1Methods of treating cancerIFM DUE INC·Filed 2021·Application pending·0 cites
- 2154US2024083879A1Oxalamide compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2022·Application pending·0 cites
- 2254US2024122903A1Methods of treating cancerIFM DUE INC·Filed 2021·Application pending·0 cites
- 2354US2024308978A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2022·Application pending·0 cites
- 2454US2022387397A1Compounds and compositions for treating conditions associated with nlrp activityNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2553US2024051970A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2021·Application pending·0 cites
- 2653US2021395241A1Nlrp modulatorsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2753US2024060982A1Methods of treating cancerIFM DUE INC·Filed 2021·Application pending·0 cites
- 2852US2023271941A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2021·Application pending·0 cites
- 2952US2023250106A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2021·Application pending·0 cites
- 3052US2022024906A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2021·Application pending·0 cites
- 3152US2023250088A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2021·Application pending·0 cites
- 3252US2023365553A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2021·Application pending·0 cites
- 3350US2023063462A1Sulfonimidamide compounds and compositions for treating conditions associated with nlrp activityNOVARTIS AG·Filed 2020·Application pending·0 cites
- 3449US2023115274A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2020·Application pending·0 cites
- 3549US2023127839A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2020·Application pending·0 cites
- 3649US2022339169A1Methods of treating or selecting a treatment for a subject resistant to tnf inhibitor using a nlrp3 antagonistNOVARTIS AG·Filed 2019·Application pending·0 cites
- 3748US12134611B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2019·Granted Nov 5, 2024·0 cites·20 claims
- 3848US2023002320A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2020·Application pending·0 cites
- 3948US2023021448A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2020·Application pending·0 cites
- 4048US2023059136A1The compounds and compositions for treating conditions associated with nlrp activityNOVARTIS AG·Filed 2019·Application pending·0 cites
- 4148US2023031406A1Compounds and compositions for treating conditions associated with nlrp activityNOVARTIS AG·Filed 2019·Application pending·0 cites
- 4248US2023051589A1Compounds and compositions for treating conditions associated with nlrp activityNOVARTIS AG·Filed 2019·Application pending·0 cites
- 4347US2023002373A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2020·Application pending·0 cites
- 4447US2023106899A1Methods of treating cancerIFM DUE INC·Filed 2020·Application pending·0 cites
- 4547US2023011652A1Compounds and compositions for treating conditions associated with nlrp activityNOVARTIS AG·Filed 2019·Application pending·0 cites
- 4646US2022388957A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2020·Application pending·0 cites
- 4746US2022267276A1Nlrp modulatorsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 4844US7750032B2Compounds and compositions as PPAR modulatorsIRM LLC·Filed 2006·Granted Jul 6, 2010·0 cites·9 claims
- 4943US11718631B2Sulphonamides and compositions thereof for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2018·Granted Aug 8, 2023·0 cites·2 claims
- 5043US2023047905A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2019·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →